ADTX חוב כולל להון Aditxt, Inc.

The linear price action on the Aditxt (ADTX) total debt-to-equity chart is recorded at 0.00. Aditxt (ADTX) is implementing environmental standards in biopharmaceuticals, strictly adhering to research ethics and data security. The business relies on expanding its network of institutional clients, while scaling is facilitated by cloud services and unified diagnostic tests for immunity correction.

The total debt-to-equity ratio measures a business's reliance on borrowed funds by comparing all liabilities against shareholder equity. By analyzing the historical debt-to-equity trend, an investor will see Aditxt's critical need for loans to finance development and acquisitions amid a deficit of operating profit and a lack of stable revenue streams.